Results 11 to 20 of about 924,741 (263)

Key elements in the quality assessment of a type 3 medication review [PDF]

Frontiers in Pharmacology, 2023
Background: Medication reviews are a structured evaluation of a patient’s pharmacotherapy with the aim of optimizing medicines use and improving health outcomes. This entails detecting drug related problems and recommending interventions. A high level of
Anneleen Robberechts, Anneleen Robberechts, Anneleen Robberechts, Melissa Michielsen, Stephane Steurbaut, Stephane Steurbaut, Guido R. Y. De Meyer, Hans De Loof   +7 more
doaj   +2 more sources

Effects of a community pharmacy-based structured medication review on drug-related problems in all-comers with polypharmacy: a randomized, controlled, double-blind, parallel-group trial [PDF]

Frontiers in Medicine
BackgroundMedication reviews may help to reduce the burdens of polypharmacy. A medication review type 2a is a structured evaluation of a patient’s pharmacotherapy based on medication history and patient information in a face-to-face interview.MethodsThis
Thorsten Bischof, Alexander Schmidt-Ilsinger, Magdalena Hoppel, Anton Kreuzer, Stefanie Briganser, Philipp Saiko, Susanne Ergott-Badawi, Raimund Podroschko, Stephan Moser, Michael Kossmeier, Bernd Jilma, Stefan Deibl, Christian Schoergenhofer   +12 more
doaj   +2 more sources

Medication Review: What’s in a Name and What Is It about? [PDF]

Pharmacy
Background: Medication review is a multifaceted service aimed at optimizing the use of medicines and enhancing the health outcomes of patients. Due to its complexity, it is crucial to clearly describe the service, its variants, and its components to ...
Anneleen Robberechts, Maja Brumer, Victoria Garcia-Cardenas, Niurka M. Dupotey, Stephane Steurbaut, Guido R. Y. De Meyer, Hans De Loof   +6 more
doaj   +2 more sources

Use of an Electronic Medication Management Support System in Patients with Polypharmacy in General Practice: A Quantitative Process Evaluation of the AdAM Trial

Pharmaceuticals, 2022
Polypharmacy is associated with a risk of negative health outcomes. Potentially inappropriate medications, interactions resulting from contradicting medical guidelines, and inappropriate monitoring, all increase the risk.
Robin Brünn, Dorothea Lemke, Jale Basten, Petra Kellermann-Mühlhoff, Juliane Köberlein-Neu, Christiane Muth, Marjan van den Akker, on behalf of the AdAM Study Group   +7 more
doaj   +1 more source

Drug-Related Problems of Patients in Primary Health Care Institutions: A Systematic Review

Frontiers in Pharmacology, 2021
Introduction: Drug-related problems (DRPs) are not only detrimental to patients' physical health and quality of life but also lead to a serious waste of health care resources. The condition of DRPs might be more severe for patients in primary health care
Xiao-Feng Ni, Xiao-Feng Ni, Xiao-Feng Ni, Xiao-Feng Ni, Chun-Song Yang, Chun-Song Yang, Chun-Song Yang, Yu-Mei Bai, Zi-Xian Hu, Ling-Li Zhang, Ling-Li Zhang, Ling-Li Zhang, Ling-Li Zhang   +12 more
doaj   +1 more source

A Collaborative Deprescribing Intervention in a Subacute Medical Outpatient Clinic: A Pilot Randomized Controlled Trial

Metabolites, 2021
Medication deprescribing is essential to prevent inappropriate medication use in multimorbid patients. However, experience of deprescribing in Danish Subacute Medical Outpatient Clinics (SMOCs) is limited. The objective of our pilot study was to evaluate
Anissa Aharaz, Jens Henning Rasmussen, Helle Bach Ølgaard McNulty, Arne Cyron, Pia Keinicke Fabricius, Anne Kathrine Bengaard, Hayley Rose Constance Sejberg, Rikke Rie Løvig Simonsen, Charlotte Treldal, Morten Baltzer Houlind   +9 more
doaj   +1 more source

Recommendations for community pharmacy to improve access to medication advice for people from ethnic minority communities: A qualitative person‐centred codesign study

Health Expectations, 2022
Introduction Medicines‐centred consultations are vital to support medicine effectiveness and optimize health outcomes for patients. However, inequalities negatively impact ethnic minority populations when accessing medicines advice.
Anna Robinson, Nicola O'Brien, Laura Sile, Harpreet K. Guraya, Thorrun Govind, Vicki Harris, Guy Pilkington, Adam Todd, Andy Husband   +8 more
doaj   +1 more source

Screening for severe drug-drug interactions in patients with multiple sclerosis: A comparison of three drug interaction databases

Frontiers in Pharmacology, 2022
Background: Patients with multiple sclerosis (MS) often undergo complex treatment regimens, resulting in an increased risk of polypharmacy and potential drug-drug interactions (pDDIs).
Michael Hecker, Niklas Frahm, Paula Bachmann, Jane Louisa Debus, Marie-Celine Haker, Pegah Mashhadiakbar, Silvan Elias Langhorst, Julia Baldt, Julia Baldt, Barbara Streckenbach, Barbara Streckenbach, Felicita Heidler, Uwe Klaus Zettl   +12 more
doaj   +1 more source

Medication reviews [PDF]

British Journal of Clinical Pharmacology, 2012
Recent years have seen a formalization of medication review by pharmacists in all settings of care. This article describes the different types of medication review provided in primary care in the UK National Health Service (NHS), summarizes the evidence of effectiveness and considers how such reviews might develop in the future.
Alison, Blenkinsopp, Christine, Bond, David K, Raynor   +2 more
openaire   +2 more sources

Perspectives of pharmacists in general practice from qualitative focus groups with patients during a pilot study

BJGP Open, 2022
Background: Utilising skill mix in general practice is proposed as a solution to the demand–supply issue. Pharmacists can play an important role in this context, leading to an increase in training and funding for independent prescriber roles.
Claire Mann, Claire Anderson, Matthew Boyd, Yasmin Karsan, Tristan Emerson   +4 more
doaj   +1 more source